{"id":"https://openalex.org/W1990704394","doi":"https://doi.org/10.1191/1352458505ms1126oa","title":"Randomized study of once-weekly interferon \u03b2-1a therapy in relapsing multiple sclerosis: three-year data from the OWIMS study","display_name":"Randomized study of once-weekly interferon \u03b2-1a therapy in relapsing multiple sclerosis: three-year data from the OWIMS study","publication_year":2005,"publication_date":"2005-01-29","ids":{"openalex":"https://openalex.org/W1990704394","doi":"https://doi.org/10.1191/1352458505ms1126oa","mag":"1990704394","pmid":"https://pubmed.ncbi.nlm.nih.gov/15732265"},"language":"en","primary_location":{"id":"doi:10.1191/1352458505ms1126oa","doi":"https://doi.org/10.1191/1352458505ms1126oa","is_oa":false,"landing_page_url":"https://doi.org/10.1191/1352458505ms1126oa","pdf_url":null,"source":{"id":"https://openalex.org/S136332993","display_name":"Multiple Sclerosis Journal","issn_l":"1352-4585","issn":["1352-4585","1477-0970"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Multiple Sclerosis Journal","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5021092653","display_name":"Mark Steven Freedman","orcid":"https://orcid.org/0000-0003-1255-9701","observed_orcids":["https://orcid.org/0000-0003-1255-9701"]},"institutions":[{"id":"https://openalex.org/I2800722420","display_name":"Ottawa Hospital","ror":"https://ror.org/03c62dg59","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2800722420"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"M S Freedman","raw_affiliation_strings":["Ottawa Hospital-General Campus, Ottawa, Ontario, Canada,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ottawa Hospital-General Campus, Ottawa, Ontario, Canada,","institution_ids":["https://openalex.org/I2800722420"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111941085","display_name":"G. Francis","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G S Francis","raw_affiliation_strings":["Serono Inc., Rockland, MA, USA, Elan Pharmaceuticals"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Serono Inc., Rockland, MA, USA, Elan Pharmaceuticals","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112248486","display_name":"Evert A. C. M. Sanders","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117191","display_name":"Ignatius Hospital","ror":"https://ror.org/023r6xh67","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210117191"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"E ACM Sanders","raw_affiliation_strings":["Ignatius Hospital, Breda, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ignatius Hospital, Breda, the Netherlands","institution_ids":["https://openalex.org/I4210117191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021069460","display_name":"G. P. A. Rice","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210094837","display_name":"University Hospital","ror":"https://ror.org/00r664k32","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2800925808","https://openalex.org/I4210094837"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"G PA Rice","raw_affiliation_strings":["Multiple Sclerosis Clinic, University Hospital, London, Ontario, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Multiple Sclerosis Clinic, University Hospital, London, Ontario, Canada","institution_ids":["https://openalex.org/I4210094837"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101430842","display_name":"Paul W O'Connor","orcid":"https://orcid.org/0000-0002-5632-8385","observed_orcids":["https://orcid.org/0000-0002-5632-8385"]},"institutions":[{"id":"https://openalex.org/I1297363086","display_name":"St. Michael's Hospital","ror":"https://ror.org/04skqfp25","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1297363086","https://openalex.org/I4399598460"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"P O'Connor","raw_affiliation_strings":["St Michael Hospital, Toronto, Ontario, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"St Michael Hospital, Toronto, Ontario, Canada","institution_ids":["https://openalex.org/I1297363086"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110202258","display_name":"Giancarlo Comi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210133214","display_name":"IRCCS Ospedale San Raffaele","ror":"https://ror.org/039zxt351","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210133214","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"G Comi","raw_affiliation_strings":["Centro Sclerosi Multipla, Ospedale San Raffaele, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centro Sclerosi Multipla, Ospedale San Raffaele, Milan, Italy","institution_ids":["https://openalex.org/I4210133214"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051605203","display_name":"Pierre Duquette","orcid":"https://orcid.org/0000-0001-7231-1754","observed_orcids":["https://orcid.org/0000-0001-7231-1754"]},"institutions":[{"id":"https://openalex.org/I4210107362","display_name":"H\u00f4pital Notre-Dame","ror":"https://ror.org/01w7qz648","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2801902503","https://openalex.org/I4210107362","https://openalex.org/I4210139015","https://openalex.org/I4210142730","https://openalex.org/I4405279980"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"P Duquette","raw_affiliation_strings":["H\u00f4pital Notre-Dame, Montr\u00e9al, Qu\u00e9bec, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H\u00f4pital Notre-Dame, Montr\u00e9al, Qu\u00e9bec, Canada","institution_ids":["https://openalex.org/I4210107362"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085566077","display_name":"Luanne M. Metz","orcid":"https://orcid.org/0000-0002-9868-6842","observed_orcids":["https://orcid.org/0000-0002-9868-6842"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L Metz","raw_affiliation_strings":["Foothills Hospital, Calgary, Alberta, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Foothills Hospital, Calgary, Alberta, Canada","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"T J Murray","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800264117","display_name":"Queen Elizabeth II Health Sciences Centre","ror":"https://ror.org/025qrzc85","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2800264117","https://openalex.org/I2802394193"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"T J Murray","raw_affiliation_strings":["Queen Elizabeth II Health Sciences Centre (Centre for Clinical Research), Halifax, Nova Scotia, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Queen Elizabeth II Health Sciences Centre (Centre for Clinical Research), Halifax, Nova Scotia, Canada","institution_ids":["https://openalex.org/I2800264117"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102087509","display_name":"J-P Bouchard","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210133239","display_name":"H\u00f4pital de l'Enfant-J\u00e9sus","ror":"https://ror.org/02p1gpn45","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2801902503","https://openalex.org/I4210133239","https://openalex.org/I4210139015","https://openalex.org/I4405257837","https://openalex.org/I4405279980"]},{"id":"https://openalex.org/I4405257837","display_name":"CHU de Qu\u00e9bec-Universit\u00e9 Laval","ror":"https://ror.org/05qn5kv73","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2801902503","https://openalex.org/I4210139015","https://openalex.org/I4405257837","https://openalex.org/I4405279980"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"J-P Bouchard","raw_affiliation_strings":["H\u00f4pital de l\u2019Enfant J\u00e9sus, Quebec City,                         Qu\u00e9bec, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H\u00f4pital de l\u2019Enfant J\u00e9sus, Quebec City,                         Qu\u00e9bec, Canada","institution_ids":["https://openalex.org/I4210133239","https://openalex.org/I4405257837"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104274843","display_name":"Oded Abramsky","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2799899409","display_name":"Hadassah Medical Center","ror":"https://ror.org/01cqmqj90","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I2799899409"]}],"countries":["IL"],"is_corresponding":false,"raw_author_name":"O Abramsky","raw_affiliation_strings":["Hadassah Medical Centre, Jerusalem, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hadassah Medical Centre, Jerusalem, Israel","institution_ids":["https://openalex.org/I2799899409"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054006135","display_name":"Jean Pelletier","orcid":"https://orcid.org/0000-0001-9730-7567","observed_orcids":["https://orcid.org/0000-0001-9730-7567"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J Pelletier","raw_affiliation_strings":["Service de Neurologie, Centre Hospitalier Universitaire de Marseille, Marseille, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Service de Neurologie, Centre Hospitalier Universitaire de Marseille, Marseille, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029156957","display_name":"Fanny O\u2019Brien","orcid":"https://orcid.org/0000-0002-5840-4089","observed_orcids":["https://orcid.org/0000-0002-5840-4089"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"F O'Brien","raw_affiliation_strings":["Serono Inc., Rockland, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Serono Inc., Rockland, MA, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":null,"display_name":"OWIMS Study Group","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"OWIMS Study Group","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":10,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4400,"currency":"USD","value_usd":4400},"apc_paid":null,"fwci":3.2079,"has_fulltext":false,"cited_by_count":40,"citation_normalized_percentile":{"value":0.90860548,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"11","issue":"1","first_page":"41","last_page":"45"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11668","display_name":"interferon and immune responses","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/interferon-beta-1a","display_name":"interferon beta-1a","score":0.9750000238418579},{"id":"https://openalex.org/keywords/relapsing-remitting-multiple-sclerosis","display_name":"relapsing-remitting multiple sclerosis","score":0.9319999814033508},{"id":"https://openalex.org/keywords/once-weekly-dosing","display_name":"weekly dosing","score":0.9570000171661377},{"id":"https://openalex.org/keywords/mri-lesion-activity","display_name":"MRI lesion activity","score":0.7570000290870667},{"id":"https://openalex.org/keywords/annualized-relapse-rate","display_name":"annualized relapse rate","score":0.9049999713897705},{"id":"https://openalex.org/keywords/neutralizing-antibodies","display_name":"neutralizing antibodies","score":0.9100000262260437},{"id":"https://openalex.org/keywords/long-term-efficacy-and-safety","display_name":"long-term efficacy and safety","score":0.7400000095367432},{"id":"https://openalex.org/keywords/dose-comparison","display_name":"dose comparison","score":0.6729999780654907}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.904039740562439},{"id":"https://openalex.org/C2780640218","wikidata":"https://www.wikidata.org/wiki/Q8277","display_name":"Multiple sclerosis","level":2,"score":0.8423590660095215},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.8096303343772888},{"id":"https://openalex.org/C143409427","wikidata":"https://www.wikidata.org/wiki/Q161238","display_name":"Magnetic resonance imaging","level":2,"score":0.6143314242362976},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5919830799102783},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.5207850337028503},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.520581066608429},{"id":"https://openalex.org/C2781156865","wikidata":"https://www.wikidata.org/wiki/Q827023","display_name":"Lesion","level":2,"score":0.5048514008522034},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.41125357151031494},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.30721592903137207},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.19519874453544617},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.194230318069458},{"id":"https://openalex.org/C126838900","wikidata":"https://www.wikidata.org/wiki/Q77604","display_name":"Radiology","level":1,"score":0.14488139748573303},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000068556","descriptor_name":"Interferon beta-1a","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000276","descriptor_name":"Adjuvants, Immunologic","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000906","descriptor_name":"Antibodies","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008279","descriptor_name":"Magnetic Resonance Imaging","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016899","descriptor_name":"Interferon-beta","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D020529","descriptor_name":"Multiple Sclerosis, Relapsing-Remitting","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D020529","descriptor_name":"Multiple Sclerosis, Relapsing-Remitting","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D020529","descriptor_name":"Multiple Sclerosis, Relapsing-Remitting","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1191/1352458505ms1126oa","doi":"https://doi.org/10.1191/1352458505ms1126oa","is_oa":false,"landing_page_url":"https://doi.org/10.1191/1352458505ms1126oa","pdf_url":null,"source":{"id":"https://openalex.org/S136332993","display_name":"Multiple Sclerosis Journal","issn_l":"1352-4585","issn":["1352-4585","1477-0970"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Multiple Sclerosis Journal","raw_type":"journal-article"},{"id":"pmid:15732265","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15732265","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Multiple sclerosis (Houndmills, Basingstoke, England)","raw_type":"Clinical Trial"},{"id":"pmh:oai:dial.uclouvain.be:boreal:60848","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/2078.1/60848","pdf_url":null,"source":{"id":"https://openalex.org/S4306401974","display_name":"DIAL (Catholic University of Leuven)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I99464096","host_organization_name":"KU Leuven","host_organization_lineage":["https://openalex.org/I99464096"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Multiple Sclerosis : clinical and laboratory research, Vol. 11, p. S180-S181 (2005)","raw_type":"info:eu-repo/semantics/conferenceObject"},{"id":"pmh:oai:iris.unisr.it:20.500.11768/16180","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/20.500.11768/16180","pdf_url":null,"source":{"id":"https://openalex.org/S7407055348","display_name":"Archivio Istituzionale della Ricerca - Universit\u00e0 Vita-Salute San Raffaele","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320323180","display_name":"University of British Columbia","ror":"https://ror.org/03rmrcq20"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":14,"referenced_works":["https://openalex.org/W1983999022","https://openalex.org/W1984327456","https://openalex.org/W2018080001","https://openalex.org/W2061005334","https://openalex.org/W2088499363","https://openalex.org/W2095666175","https://openalex.org/W2105477343","https://openalex.org/W2139367012","https://openalex.org/W2168301183","https://openalex.org/W2169098250","https://openalex.org/W2313649737","https://openalex.org/W2509277703","https://openalex.org/W4210548604","https://openalex.org/W4244801936"],"related_works":["https://openalex.org/W4244801936","https://openalex.org/W1983999022","https://openalex.org/W2042710369","https://openalex.org/W2061005334","https://openalex.org/W6939967938","https://openalex.org/W2021850497","https://openalex.org/W7218190354","https://openalex.org/W2114225021","https://openalex.org/W2897828241","https://openalex.org/W2035453515"],"abstract_inverted_index":{"BACKGROUND:":[0],"Once":[1],"weekly":[2,162],"interferon":[3,21],"beta-1a":[4,23,45,199],"for":[5,64,96,101,106,111,123],"multiple":[6,48],"sclerosis":[7,49],"(OWIMS)":[8],"demonstrated":[9],"modest,":[10],"but":[11,27,141,173],"significant,":[12],"magnetic":[13],"resonance":[14],"imaging":[15],"(MRI)":[16],"benefit":[17,211],"of":[18,39,42,196,208],"once-weekly":[19,213],"(qw)":[20],"(IFN)":[22],"at":[24],"48":[25],"weeks,":[26],"no":[28],"significant":[29,171,181,190],"effect":[30,183,191],"on":[31],"relapses.":[32],"OBJECTIVE:":[33],"An":[34],"OWIMS":[35],"extension":[36],"permitted":[37],"assessment":[38],"longer-term":[40],"efficacy/safety":[41],"qw":[43],"IFN":[44,57,163,198],"in":[46,147],"relapsing-remitting":[47],"(RRMS).":[50],"METHODS:":[51],"Placebo":[52],"patients":[53,149],"were":[54,81,121,145],"rerandomized":[55],"to":[56,154,188],"beta-1a,":[58,164],"22":[59,102],"or":[60],"44":[61,97,124,151,166],"mcg":[62,113,125,152],"qw,":[63],"two":[65],"additional":[66],"48-week":[67],"intervals.":[68],"Primary":[69],"outcome":[70],"was":[71,93,184],"MRI":[72,79,142],"lesion":[73,91],"activity.":[74],"Relapse":[75],"rate":[76],"and":[77],"other":[78,128],"measures":[80],"secondary":[82],"outcomes.":[83],"RESULTS:":[84],"After":[85],"three":[86],"years,":[87],"median":[88],"(mean)":[89],"T2":[90],"count/patient/scan":[92],"1.3":[94],"(2.6)":[95],"mcg,":[98,103,108,167],"1.7":[99,104],"(3.3)":[100],"(3.4)":[105],"placebo/22":[107],"2.0":[109],"(3.6)":[110],"placebo/44":[112],"(all":[114],"differences":[115],"not":[116,131,137,174],"significant).":[117,132],"Annualized":[118],"relapse":[119,139],"rates":[120],"lowest":[122],"(0.77)":[126],"versus":[127],"groups":[129],"(0.83-0.86,":[130],"Persistent":[133],"neutralizing":[134],"antibodies":[135],"did":[136],"affect":[138],"rates,":[140],"active":[143],"lesions":[144],"increased":[146],"antibody-positive":[148],"receiving":[150],"compared":[153,177,200],"antibody":[155],"negative":[156],"patients.":[157],"CONCLUSIONS:":[158],"In":[159,186],"RRMS,":[160],"once":[161],"particularly":[165],"can":[168],"induce":[169],"a":[170],"MRI,":[172],"relapse,":[175],"effect,":[176],"with":[178,193,201,212],"placebo.":[179],"No":[180],"dose":[182],"seen.":[185],"contrast":[187],"the":[189,206],"observed":[192],"three-times-weekly":[194],"dosing":[195],"subcutaneous":[197],"placebo,":[202],"this":[203],"study":[204],"confirms":[205],"lack":[207],"meaningful":[209],"clinical":[210],"dosing.":[214]},"counts_by_year":[{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":2},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-05T12:25:35.769452","created_date":"2016-06-24T00:00:00"}